Amantadine, benefit-risk balance in severe brain injury

被引：0

|

作者：

Giacino, J. T.

机构：

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

SYMP03-1

引用

收藏

页码：4 / 4

页数：1

相关论文

共 50 条

[1] ASPECTS ON THE BENEFIT-RISK BALANCE OF FELODIPINE IN HYPERTENSION
ELMFELDT, D
WESTERLING, S
DRUGS, 1987, 34 : 132 - 135
[2] EMA reviews benefit-risk balance of domperidone
Reactions Weekly, 2013, 1448 (1) : 4 - 4
[3] Amantadine for Severe Traumatic Brain Injury
Mukherjee, Debraj
Patil, Chirag G.
Palestrant, David
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (25): : 2427 - 2427
[4] NSAIDs: risk of thrombotic events but positive benefit-risk balance
Reactions Weekly, 2006, 1125 (1) : 2 - 2
[5] Positive benefit-risk balance continues for glitazones – EMEA
Reactions Weekly, 2007, 1175 (1) : 2 - 2
[6] Drug intake and pregnancy, evaluating the benefit-risk balance
Benevent, Justine
Lacroix, Isabelle
ACTUALITES PHARMACEUTIQUES, 2019, 58 (588): : 21 - 27
[7] Positive benefit-risk balance for orlistat, finds EMA
Reactions Weekly, 2012, 1390 (1) : 2 - 2
[8] A benefit-risk assessment of baclofen in severe spinal spasticity
Dario, A
Tomei, G
DRUG SAFETY, 2004, 27 (11) : 799 - 818
[9] Levothyroxine Alapis: risk of med errors tips benefit-risk balance
Reactions Weekly, 2012, 1426 (1) : 4 - 4
[10] A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity
Alessandro Dario
Giustino Tomei
Drug Safety, 2004, 27 : 799 - 818

← 1 2 3 4 5 →